The American Diabetes Reality Check
More than 38 million Americans live with diabetes, and another 98 million adults have prediabetes, according to the CDC. That means roughly one in three people you know is dealing with blood sugar questions on a regular basis. The challenge is that "checking your sugar" no longer means one thing. You have traditional fingerstick meters that have been the standard for decades, and you have continuous glucose monitors (CGMs) that have exploded in popularity since the FDA cleared the first over-the-counter versions in 2024.
The real problem most people face is not a lack of options. It is knowing which option matches their actual needs. A 68-year-old retiree in Phoenix managing type 2 diabetes with oral medication has different requirements than a 34-year-old marathon runner in Portland tracking glucose for performance. And a parent in rural Texas caring for a child with type 1 diabetes needs something else entirely.
Cost adds another layer of confusion. A prescription CGM like Dexcom G7 can run roughly $350–400 per month without coverage, while over-the-counter options like Stelo or Lingo cost around $49–99 per month. Traditional meters and test strips are far cheaper upfront but require you to remember to test multiple times daily.
Breaking Down Your Blood Sugar Monitor Options
The market splits into three clear categories, and understanding the difference saves you both money and frustration.
Traditional Blood Glucose Meters
These are the classic fingerstick devices. You prick your fingertip, place a drop of blood on a test strip, and get a reading in about five seconds. They are inexpensive, widely available at any pharmacy, and covered by Medicare Part B as durable medical equipment. Part B covers the monitor, test strips (up to 100 per month for non-insulin users, 300 for insulin users), lancets, and control solution after you meet the deductible. You pay 20% of the Medicare-approved amount after that.
The downside is obvious: you only see snapshots, not the full picture. A reading two hours after breakfast tells you where you landed, but it does not show the spike that happened 45 minutes in, or the slow drop through the afternoon.
Prescription Continuous Glucose Monitors
CGMs use a tiny sensor inserted just under the skin that measures glucose in interstitial fluid every few minutes and streams data to your phone. Dexcom G7 and FreeStyle Libre 3 Plus are the two dominant prescription options, and both are covered by Medicare Part B if you take insulin or have a history of hypoglycemia, and if your doctor prescribes them and you complete training.
Without coverage, Dexcom G7 runs about $350–400 per month at most US pharmacies. FreeStyle Libre 3 Plus is more budget-friendly at roughly $160 per month. Both offer real-time alerts for dangerously high or low glucose, which is why they are the standard for insulin users.
Over-the-Counter CGMs
This is the category that changed everything. Dexcom Stelo became the first FDA-cleared OTC glucose biosensor in March 2024, followed by Abbott's Lingo later that year. These do not require a prescription, are designed for adults 18 and older who are not on insulin, and focus on metabolic health and wellness rather than emergency alerts.
Stelo costs about $99 for a box of two 15-day sensors, roughly $89 per month on a subscription. Lingo runs about $49–89 per month depending on the plan length. You can buy them at major retailers including CVS, Walmart, and Target, or directly from the manufacturers, and they are HSA and FSA eligible.
A Side-by-Side Look at the Main Contenders
| Device | Prescription Needed | Approximate Monthly Cost | Best For | Key Strengths | Trade-offs |
|---|
| Dexcom Stelo | No | $89–99 | Adults not on insulin tracking metabolic health | 15-day wear, accurate (about 8.3% MARD), works with Apple Health and Android | No urgent low-glucose alerts |
| Abbott Lingo | No | $49–89 | Budget-conscious beginners wanting built-in coaching | Lowest entry price, coaching app with daily scores | Best price requires multi-month commitment |
| Dexcom G7 | Yes | $350–400 | Insulin users needing real-time alerts | Predictive low alerts, pump integration, 10–15 day wear | Expensive without coverage |
| FreeStyle Libre 3 Plus | Yes | ~$160 | Type 2 patients on insulin wanting accuracy at lower cost | Comparable accuracy (about 8.9% MARD), 15-day sensors | Requires prescription and clinician setup |
| Traditional meters (e.g., OneTouch, Contour) | No | $20–60 for meter; strips vary | Anyone needing spot checks with minimal tech | Cheap, reliable, Medicare-covered | Only shows single readings, no trends |
Practical Steps to Pick Your Blood Sugar Monitor
Start by talking to your care team about your specific targets. For most adults, the goal is a reading between 80 and 130 mg/dL before meals and under 180 mg/dL two hours after a meal. If you are not sure what range makes sense for your age and health conditions, that conversation comes first.
If you take insulin or have frequent low blood sugar episodes, a prescription CGM is the medically appropriate choice. Ask your doctor about Medicare coverage — Part B has covered CGMs since 2023 for qualifying patients, and the process involves a prescription, training, and using a Medicare-enrolled supplier.
If you are managing type 2 diabetes without insulin, or you simply want to understand how food, exercise, and sleep affect your glucose, an OTC sensor like Stelo or Lingo is worth trying for a month. Many people report that seeing their glucose response to a specific meal changes their eating habits faster than any diet advice ever did.
If you are on a tight budget or prefer minimal technology, a traditional meter remains a perfectly valid tool. Just be honest about whether you will actually test at the recommended times — before meals, two hours after meals, and at bedtime. A meter you use is better than a CGM you ignore.
Regional Resources and Real-World Experience
Across the US, the practical details matter. In states with large Medicare populations like Florida and Arizona, diabetes educators at local clinics are often the best first stop for understanding coverage options. In tech-forward cities like Austin and Seattle, you will find metabolic health clinics and wellness programs that incorporate CGM data into coaching. Rural communities in states like Texas and Kansas may have fewer specialist options, but telehealth diabetes education programs have expanded significantly, and major pharmacy chains in most mid-sized towns stock OTC sensors.
Take Sarah from Ohio, for example. She is 52, manages type 2 diabetes with metformin, and her A1C hovered around 7.5% for years. Her doctor suggested she try Stelo for three months. Within the first week, she saw that her morning oatmeal was causing a bigger spike than she expected, and that a short walk after dinner flattened her evening curve. Her A1C dropped to 6.8% at her next check, and she now uses the sensor seasonally to stay accountable.
Or consider Marcus in Georgia, 61, on Medicare with type 2 diabetes and insulin. His endocrinologist prescribed FreeStyle Libre 3 Plus, and Medicare Part B covers most of the cost after his deductible. The real-time low alerts have caught two nighttime hypoglycemia episodes that he would have slept through before. That alone made the device worth it for his family.
Making the Numbers Work
Insurance coverage varies widely by plan, so the first move is checking what your plan covers rather than assuming. Medicare Part B covers traditional meters, strips, and CGMs for qualifying patients, with you paying 20% after the deductible. Private insurance plans vary, but most major plans now cover prescription CGMs for insulin users, and some cover OTC options through flexible spending accounts.
For people paying out of pocket, the OTC category is the game changer. At $89–99 per month, Stelo costs less than many people spend on coffee, and it delivers far more insight than any single daily fingerstick. Abbott's Lingo can be even cheaper on longer plans, around $49 per month with a six-month commitment.
Manufacturer savings programs also exist for prescription devices. Dexcom and Abbott both offer assistance options for uninsured or underinsured patients that can meaningfully reduce out-of-pocket costs, so it is worth checking their websites before paying full list price.
A Final Thought on Consistency
The best blood sugar monitor is the one you actually use. A CGM gives you a constant stream of data, but it only helps if you review the trends and act on them. A fingerstick meter works fine if you build testing into your routine. The people who see real improvement in their numbers are not the ones with the fanciest device — they are the ones who treat monitoring as a tool for learning, not a chore.
If you are just starting out, consider a one-month trial of an OTC sensor to see how your body responds to different foods and activities. Pair that with a conversation with your care team about your targets. From there, you will know whether a subscription makes sense or whether a traditional meter keeps you on track. Either way, the data you collect is the foundation of better decisions, and that is the real win.
研究の知恵